Tracking LA’s Life Sciences Growth
Both investment in and demand for life sciences space are rising in Los Angeles, further establishing the sector as one of the fastest-growing alternative asset classes after the pandemic.
CBRE’s most recent national life sciences report shows increasing developer interest in Los Angeles. For example, CoStar reported this week that BEP Helix, led by biotech investor Ben Pouladian, is set to buy the leasehold interest in the 280,000-square-foot Park DTLA office building and will convert it into a life sciences campus. And last month, the University of Southern California agreed to pay $57 million for a 75,272-square-foot life sciences building at the Health Sciences Campus east of Downtown L.A.
READ FULL ARTICLE HERE